Document is current
Any future updates will be listed below
-
Authors
Nogueira-Recalde, Uxía
Lambertucci, Flavia
Montégut, Léa https://orcid.org/0000-0003-4778-4757
Motiño, Omar https://orcid.org/0000-0002-3858-0966
Chen, Hui https://orcid.org/0000-0002-1260-8617
Lachkar, Sylvie
Anagnostopoulos, Gerasimos https://orcid.org/0000-0002-2042-8675
Stoll, Gautier https://orcid.org/0000-0002-0862-4139
Li, Sijing
Carbonier, Vincent
Saavedra Díaz, Ester
Blanco, Francisco J. https://orcid.org/0000-0001-9821-7635
van Tetering, Geert
de Boer, Mark
Maiuri, Maria Chiara
Caramés, Beatriz
Martins, Isabelle https://orcid.org/0000-0003-0885-613X
Kroemer, Guido https://orcid.org/0000-0002-9334-4405
- License Information
-
More Information
Article History
Received: 30 October 2024
Revised: 6 February 2025
Accepted: 24 February 2025
First Online: 13 March 2025
Competing interests
: IM is a consultant for Osasuna Therapeutics. GK has been holding research contracts with Daiichi Sankyo, Eleor, Kaleido, Lytix Pharma, PharmaMar, Osasuna Therapeutics, Samsara Therapeutics, Sanofi, Sutro, Tollys, and Vascage. GK is on the Board of Directors of the Bristol Myers Squibb Foundation France. GK is a scientific co-founder of everImmune, Osasuna Therapeutics, Samsara Therapeutics, and Therafast Bio. GK is in the scientific advisory boards of Hevolution, Institut Servier, Longevity Vision Funds, and Rejuveron Life Sciences. GK is the inventor of patents covering therapeutic targeting of aging, cancer, cystic fibrosis, and metabolic disorders. GK’s wife, Laurence Zitvogel, has held research contracts with Glaxo Smyth Kline, Incyte, Lytix, Kaleido, Innovate Pharma, Daiichi Sankyo, Pilege, Merus, Transgene, 9m, Tusk, and Roche, was on the Board of Directors of Transgene, is a co-founder of EverImmune, and holds patents covering the treatment of cancer and the therapeutic manipulation of the microbiota. GK’s brother, Romano Kroemer, was an employee of Sanofi and now consults for Boehringer-Ingelheim. The funders had no role in the design of the study; in the writing of the manuscript, or in the decision to publish the results.
